Ono Venture Investment, Inc. — Full Portfolio

Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.

AI & Machine LearningBiotechDeep TechHealthtech

Jane Osbourn(Chief Executive Officer)

Co-investorsSV Health InvestorsDCVC BioRA CapitalDementia Discovery FundLightstone VenturesBritish Business Bank+2 more

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.

BiotechDigital HealthMedical DevicesCambridge, US

DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)ANNIE HAZLEHURST(Director)

BoardKEITH CRANDELL(Director)DAVID R. WALT(Director)in

Co-investorsARCH Venture PartnersIllumina VenturesTCG CrossoverAlly Bridge GroupJanus Henderson InvestorsSection 32+3 more

Casma is a biotech company developing technology that uses the autophagy pathway to degrade disease targets for therapeutic applications.

BiotechDeep TechHealthtechBoston, US

Andrea Ballabio(Founder)Beth Levine(Founder)Herbert Virgin(Founder)James Hurley(Founder)in

Co-investorsAstellas Venture Management LLCThird Rock VenturesEisai Innovation, Inc.

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLaura Brass(Director)inKai Wucherpfennig(Director)

Co-investorsDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundSolasta VenturesAgent Capital+2 more

Mediartx develops novel therapies for patients with fibrotic diseases.

BiotechMedical DevicesBoston, US

Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)inBrian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)

Co-investorsLongwood FundMission BiocapitalNovartis Venture FundPfizer Venture InvestmentsShangBay Capital LLCSofinnova Partners+2 more

Mission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics.

BiotechDeep TechSan Francisco, US

BoardDouglas Crawford, PhD(Managing General Partner)Peter Parker(Managing General Partner)

Co-investorsConnecticut Innovations

Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.

BiotechMedical Devices

Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in

Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundPfizer Venture InvestmentsSofinnova PartnersAlexandria+3 more

Photys Therapeutics develops bifunctional small-molecule medicines that use induced proximity to recruit kinases and drive targeted protein phosphorylation, aiming to modulate and repair disease-driving proteins.

BiotechHealthtechLongevityWaltham, US

Amit Choudhary(Scientific Founder)David Steinberg(Chairman & Founding CEO)inEdward Holson(Co-founder & CSO)inLizzie Ngo(Co-founder)inBrian Fenton(President & CEO)in

Co-investorsLongwood FundMPM BioImpact8VCMRL Ventures Fund

Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)

BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDylan Morris(Director)

Co-investorsBold Capital PartnersCRV (Charles River Ventures)FREEFLOWGlobal BrainUpfront VenturesDigitalis Ventures+2 more

Violet Labs builds software tools for engineers designing and building physical products across industries including aerospace, defense, robotics, and energy.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareHardware

Lucy Hoag(Founder)in

Co-investorsFelicis VenturesMaC Venture CapitalV1 VCDementia Discovery FundHopelabNorthwell Holdings+2 more

Violet provides free, personalised support for Australian families navigating end-of-life care, combining human connection and technology to offer practical guidance, emotional support, and tools for important conversations.

Digital HealthFintechHealthtechImpact & Social GoodMental HealthHaymarket, AU

BoardKate Carnell(Chairperson)

Co-investorsTechstarsDementia Discovery FundHopelabNorthwell HoldingsThe Venture CollectiveUTEC

Violet provides healthcare organizations with data analytics and tools to measure and improve their ability to deliver person-centered care that considers patients' individual preferences, identities, and experiences.

Data & InfrastructureDigital HealthHealthtechNew York City, US

Gaurang Choksi(CEO and Founder)inScott Zaloom(Head of Operations)inDr. Kay Nikiforova(Head of Clinical & Research)inEliot Kristan(Head of Engineering)in

Co-investorsSeae VenturesSemperVirens Venture CapitalThe Venture CollectiveW Health Ventures Gp LlcDementia Discovery FundHopelab+2 more

Cambridge, US

Co-investorsDementia DiscoverySV Health Investors

AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.

AI & Machine LearningBiotechDeep TechHealthtechStanford, US

Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in

BoardRodger Novak(Chair)

Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+2 more